Delivery Order SPE2DB22D1106-SPE2DB25FEXS6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,124.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,191.84 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, is to be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Naloxone is a critical opioid antagonist medication used in emergency medical response and...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $3,580.96 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that supplies...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,686.24 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray (2-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,928.40 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price, non-set-aside contract is classified as a child award, indicating it derives from a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $23,532.89 delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on May 16, 2025, with a completion date of May 19, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 24, 2025, with a ceiling value of $1,583.26 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery vehicle with DLA. This delivery order falls...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXS6Delivery Order
The Defense Logistics Agency awarded a $4,498.38 delivery order to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-dose units) on July 14, 2025, with a completion date of July 15, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive pharmaceutical and medical supply portfolio. This delivery order for naloxone—a life-saving medication used to reverse opioid overdoses—aligns with the company's extensive federal contracting portfolio across military and veteran healthcare systems. The prime IDC vehicle enables AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/14/25 |